FREE SHIPPING ON ORDERS OVER $150

5-amino-1mq clinical studies — 50mg | NNMT Inhibitor (NAD+ Axis) 5-Amino-1MQ 5mg & 50mg |

$24.27

Quantity
- +
Description

A 2025 study in Biomolecules found that NNMT inhibitor treatment "reduces body weight, white adipose tissue mass, total cholesterol, and adipocyte size in obese mice." These changes suggest cardiovascular benefit beyond simple weight loss

5-amino-1mq clinical studies  50mg | NNMT Inhibitor (NAD+ Axis) 5-Amino-1MQ 5mg & 50mg |

The dual mechanism was confirmed at the cellular level, and the fragment showed no cross-reactivity with the growth hormone receptor (Ng & Borstein, 2003)

5-amino-1mq clinical studies  50mg | NNMT Inhibitor (NAD+ Axis) 5-Amino-1MQ 5mg & 50mg |

It is part of the Los Flamencos National Reserve

5-amino-1mq clinical studies  50mg | NNMT Inhibitor (NAD+ Axis) 5-Amino-1MQ 5mg & 50mg |

Preclinical research suggests that by inhibiting NNMT, 5-Amino-1MQ may prevent the "waste" of Nicotinamide, thereby supporting higher intracellular NAD+ levels

5-amino-1mq clinical studies  50mg | NNMT Inhibitor (NAD+ Axis) 5-Amino-1MQ 5mg & 50mg |

GHK-Cu (Copper Tripeptide-1) GHK-Cu (Copper Tripeptide-1) is the most widely recognized copper peptide in skincare and cosmetic formulation

5-amino-1mq clinical studies  50mg | NNMT Inhibitor (NAD+ Axis) 5-Amino-1MQ 5mg & 50mg |

You may also like

recommand products